How imprinting centres work (original) (raw)

Skip Nav Destination

Article navigation

Issue Cover

Review Articles| March 30 2006

A. Lewis;

Laboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge (UK)

Search for other works by this author on:

W. Reik

Laboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge (UK)

Search for other works by this author on:

Cytogenet Genome Res (2006) 113 (1-4): 81–89.

Content Tools

Abstract

Imprinted genes tend to be clustered in the genome. Most of these clusters have been found to be under the control of discrete DNA elements called imprinting centres (ICs) which are normally differentially methylated in the germline. ICs can regulate imprinted expression and epigenetic marks at many genes in the region, even those which lie several megabases away. Some of the molecular and cellular mechanisms by which ICs control other genes and regulatory regions in the cluster are becoming clear. One involves the insulation of genes on one side of the IC from enhancers on the other, mediated by the insulator protein CTCF and higher-order chromatin interactions. Another mechanism may involve non-coding RNAs that originate from the IC, targeting histone modifications to the surrounding genes. Given that several imprinting clusters contain CTCF dependent insulators and/or non-coding RNAs, it is likely that one or both of these two mechanisms regulate imprinting at many loci. Both mechanisms involve a variety of epigenetic marks including DNA methylation and histone modifications but the hierarchy of and interactions between these modifications are not yet understood. The challenge now is to establish a chain of developmental events beginning with differential methylation of an IC in the germline and ending with imprinting of many genes, often in a lineage dependent manner.

References

Balmer D, Arredondo J, Samaco RC, LaSalle JM: MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110:545–552 (2002).

Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482–485 (2000).

Bhogal B, Arnaudo A, Dymkowski A, Best A, Davis TL: Methylation at mouse Cdkn1c is acquired during postimplantation development and functions to maintain imprinted expression. Genomics 84:961–970 (2004).

Bielinska B, Blaydes SM, Buiting K, Yang T, Krajewska-Walasek M, Horsthemke B, Brannan CI: De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch. Nat Genet 25:74–78 (2000).

Braidotti G, Baubec T, Pauler F, Seidl C, Smrzka O, Stricker S, Yotova I, Barlow DP: The Air non-coding RNA – an imprinted _cis_-silencing transcript. Cold Spring Harb Symp Quant Biol 69:55–66 (2004).

Buiting K, Lich C, Cottrell S, Barnicoat A, Horsthemke B: A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum Genet 105:665–666 (1999).

Cattanach BM, Kirk M: Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315:496–498 (1985).

Cerrato F, Dean W, Davies K, Kagotani K, Mitsuya K, Okumura K, Riccio A, Reik W: Paternal imprints can be established on the maternal Igf2-H19 locus without altering replication timing of DNA. Hum Mol Genet 12:3123–3132 (2003).

Coombes C, Arnaud P, Gordon E, Dean W, Coar EA, Williamson CM, et al: Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus. Mol Cell Biol 23:5475–5488 (2003).

Drewell RA, Brenton JD, Ainscough JF, Barton SC, Hilton KJ, Arney KL, Dandolo L, Surani MA: Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch. Development 127:3419–3428 (2000).

El-Maarri O, Buiting K, Peery EG, Kroisel PM, Balaban B, Wagner K, et al: Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nat Genet 27:341–344 (2001).

Fan T, Hagan JP, Kozlov SV, Stewart CL, Muegge K: Lsh controls silencing of the imprinted Cdkn1c gene. Development 132:635–644 (2005).

Filippova GN, Cheng MK, Moore JM, Truong JP, Hu YJ, Nguyen DK, Tsuchiya KD, Disteche CM: Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development. Dev Cell 8:31–42 (2005).

Fitzpatrick GV, Soloway PD, Higgins MJ: Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 32:426–431 (2002).

Fournier C, Goto Y, Ballestar E, Delaval K, Hever AM, Esteller M, Feil R: Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J 21:6560–6570 (2002).

Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T: The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035–4040 (2002).

Geuns E, De Rycke M, Van Steirteghem A, Liebaers I: Methylation imprints of the imprint control region of the _SNRPN_-gene in human gametes and preimplantation embryos. Hum Mol Genet 12:2873–2879 (2003).

Grandjean V, O’Neill L, Sado T, Turner B, Ferguson-Smith A: Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. FEBS Lett 488:165–169 (2001).

Gregory RI, Randall TE, Johnson CA, Khosla S, Hatada I, O’Neill LP, Turner BM, Feil R: DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol 21:5426–5436 (2001).

Gribnau J, Hochedlinger K, Hata K, Li E, Jaenisch R: Asynchronous replication timing of imprinted loci is independent of DNA methylation, but consistent with differential subnuclear localization. Genes Dev 17:759–773 (2003).

Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI: Establishment and maintenance of a heterochromatin domain. Science 297:2232–2237 (2002).

Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486–489 (2000).

Heard E: Recent advances in X-chromosome inactivation. Curr Opin Cell Biol 16:247–255 (2004).

Higashimoto K, Urano T, Sugiura K, Yatsuki H, Joh K, Zhao W, et al: Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome. Am J Hum Genet 73:948–956 (2003).

Hikichi T, Kohda T, Kaneko-Ishino T, Ishino F: Imprinting regulation of the murine Meg1/Grb10 and human GRB10 genes; roles of brain-specific promoters and mouse-specific CTCF-binding sites. Nucleic Acids Res 31:1398–1406 (2003).

Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37:31–40 (2005).

Huynh KD, Lee JT: Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos. Nature 426:857–862 (2003).

Huynh KD, Lee JT: X-chromosome inactivation: a hypothesis linking ontogeny and phylogeny. Nat Rev Genet 6:410–418 (2005).

Jackson JP, Lindroth AM, Cao X, Jacobsen SE: Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416:556–560 (2002).

Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A, Ohlsson R, Lobanenkov VV: Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 10:853–856 (2000).

Kanduri C, Fitzpatrick G, Mukhopadhyay R, Kanduri M, Lobanenkov V, Higgins M, Ohlsson R: A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator. J Biol Chem 277:18106–18110 (2002).

Khosla S, Aitchison A, Gregory R, Allen ND, Feil R: Parental allele-specific chromatin configuration in a boundary-imprinting-control element upstream of the mouse H19 gene. Mol Cell Biol 19:2556–2566 (1999).

Kim J, Kollhoff A, Bergmann A, Stubbs L: Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum Mol Genet 12:233–245 (2003).

Labrador M, Corces VG: Setting the boundaries of chromatin domains and nuclear organization. Cell 111:151–154 (2002).

Landers M, Bancescu DL, Le Meur E, Rougeulle C, Glatt-Deeley H, Brannan C, Muscatelli F, Lalande M: Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res 32:3480–3492 (2004).

Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192–1200 (2003).

Lewis A, Mitsuya K, Umlauf D, Smith P, Dean W, Walter J, et al: Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet 36:1291–1295 (2004).

Li E, Beard C, Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 366:362–365 (1993).

Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, Cavaille J, Ferguson-Smith AC: Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat Genet 35:97–102 (2003).

Linglart A, Gensure RC, Olney RC, Juppner H, Bastepe M: A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a _cis_-acting imprinting control element of GNAS. Am J Hum Genet 76:804–814 (2005).

Liu J, Yu S, Litman D, Chen W, Weinstein LS: Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 20:5808–5817 (2000).

Lopes S, Lewis A, Hajkova P, Dean W, Oswald J, Forne T, et al: Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. Hum Mol Genet 12:295–305 (2003).

Lyle R, Watanabe D, te Vruchte D, Lerchner W, Smrzka OW, Wutz A, et al: The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat Genet 25:19–21 (2000).

Mager J, Montgomery ND, de Villena FP, Magnuson T: Genome imprinting regulated by the mouse Polycomb group protein Eed. Nat Genet 33:502–507 (2003).

Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R: MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14:1049–1058 (2005).

Mancini-DiNardo D, Steele SJ, Ingram RS, Tilghman SM: A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. Hum Mol Genet 12:283–294 (2003).

McGrath J, Solter D: Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37:179–183 (1984).

Mitsuya K, Meguro M, Lee MP, Katoh M, Schulz TC, Kugoh H, et al: LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet 8:1209–1217 (1999).

Morgan HD, Santos F, Green K, Dean W, Reik W: Epigenetic reprogramming in mammals. Hum Mol Genet 14, Spec No 1:R47–R58 (2005).

Murrell A, Heeson S, Reik W: Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 36:889–893 (2004).

Ohta T, Buiting K, Kokkonen H, McCandless S, Heeger S, Leisti H, et al: Molecular mechanism of Angelman syndrome in two large families involves an imprinting mutation. Am J Hum Genet 64:385–396 (1999).

O’Neill MJ: The influence of non-coding RNAs on allele-specific gene expression in mammals. Hum Mol Genet 14, Spec No 1:R113–R120 (2005).

Pedone PV, Pikaart MJ, Cerrato F, Vernucci M, Ungaro P, Bruni CB, Riccio A: Role of histone acetylation and DNA methylation in the maintenance of the imprinted expression of the H19 and Igf2 genes. FEBS Lett 458:45–50 (1999).

Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, et al: Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms’ tumor. Proc Natl Acad Sci USA 102:4085–4090 (2005).

Purbowasito W, Suda C, Yokomine T, Zubair M, Sado T, Tsutsui K, Sasaki H: Large-scale identification and mapping of nuclear matrix-attachment regions in the distal imprinted domain of mouse chromosome 7. DNA Res 11:391–407 (2004).

Reik W, Lewis A: Co-evolution of X-chromosome inactivation and imprinting in mammals. Nat Rev Genet 6:403–410 (2005).

Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M: An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet 19:15–16 (1998).

Sado T, Fenner MH, Tan SS, Tam P, Shioda T, Li E: X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev Biol 225:294–303 (2000).

Sakamoto A, Liu J, Greene A, Chen M, Weinstein LS: Tissue-specific imprinting of the G protein Gsalpha is associated with tissue-specific differences in histone methylation. Hum Mol Genet 13:819–828 (2004).

Schweizer J, Zynger D, Francke U: In vivo nuclease hypersensitivity studies reveal multiple sites of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription unit. Hum Mol Genet 8:555–566 (1999).

Sharp AJ, Spotswood HT, Robinson DO, Turner BM, Jacobs PA: Molecular and cytogenetic analysis of the spreading of X inactivation in X;autosome translocations. Hum Mol Genet 11:3145–3156 (2002).

Shemer R, Birger Y, Riggs AD, Razin A: Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern. Proc Natl Acad Sci USA 94:10267–10272 (1997).

Sleutels F, Zwart R, Barlow DP: The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415:810–813 (2002).

Sleutels F, Tjon G, Ludwig T, Barlow DP: Imprinted silencing of Slc22a2 and Slc22a3 does not need transcriptional overlap between Igf2r and Air. EMBO J 22:3696–3704 (2003).

Soejima H, Wagstaff J: Imprinting centers, chromatin structure, and disease. J Cell Biochem 95:226–233 (2005).

Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A: Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 36:958–960 (2004).

Storz G: An expanding universe of noncoding RNAs. Science 296:1260–1263 (2002).

Surani MA, Barton SC, Norris ML: Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308:548–550 (1984).

Szabo P, Tang SH, Rentsendorj A, Pfeifer GP, Mann JR: Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol 10:607–610 (2000).

Takada S, Paulsen M, Tevendale M, Tsai CE, Kelsey G, Cattanach BM, Ferguson-Smith AC: Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19. Hum Mol Genet 11:77–86 (2002).

Tamaru H, Selker EU: A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414:277–283 (2001).

Tariq M, Saze H, Probst AV, Lichota J, Habu Y, Paszkowski J: Erasure of CpG methylation in Arabidopsis alters patterns of histone H3 methylation in heterochromatin. Proc Natl Acad Sci USA 100:8823–8827 (2003).

Thorvaldsen JL, Duran KL, Bartolomei MS: Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 12:3693–3702 (1998).

Turker MS, Bestor TH: Formation of methylation patterns in the mammalian genome. Mutat Res 386:119–130 (1997).

Umlauf D, Goto Y, Cao R, Cerqueira F, Wagschal A, Zhang Y, Feil R: Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet 36:1296–1300 (2004).

Wang J, Mager J, Chen Y, Schneider E, Cross JC, Nagy A, Magnuson T: Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet 28:371–375 (2001).

Weber M, Hagege H, Murrell A, Brunel C, Reik W, Cathala G, Forne T: Genomic imprinting controls matrix attachment regions in the Igf2 gene. Mol Cell Biol 23:8953–8959 (2003).

Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP: Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389:745–749 (1997).

Xin Z, Tachibana M, Guggiari M, Heard E, Shinkai Y, Wagstaff J: Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. J Biol Chem 278:14996–15000 (2003).

Yang Y, Li T, Vu TH, Ulaner GA, Hu JF, Hoffman AR: The histone code regulating expression of the imprinted mouse Igf2r gene. Endocrinology 144:5658–5670 (2003).

Yoon BJ, Herman H, Sikora A, Smith LT, Plass C, Soloway PD: Regulation of DNA methylation of Rasgrf1. Nat Genet 30:92–96 (2002).

Yusufzai TM, Felsenfeld G: The 5′-HS4 chicken beta-globin insulator is a CTCF-dependent nuclear matrix-associated element. Proc Natl Acad Sci USA 101:8620–8624 (2004).

© 2006 S. Karger AG, Basel

2006

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

You do not currently have access to this content.

Sign in

Digital Version

Pay-Per-View Access

$39.00

1 Karger Article Bundle Token

$150

Rental

This article is also available for rental through DeepDyve.